XP-XP Tibial Tray - Interlok 83 mm Item # 195759
FDA Device Recall #Z-2518-2019 — Class II — August 15, 2019
Recall Summary
| Recall Number | Z-2518-2019 |
| Classification | Class II — Moderate risk |
| Date Initiated | August 15, 2019 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Zimmer Biomet, Inc. |
| Location | Warsaw, IN |
| Product Type | Devices |
| Quantity | 384 units |
Product Description
XP-XP Tibial Tray - Interlok 83 mm Item # 195759
Reason for Recall
The locking bar not fully engaging
Distribution Pattern
State NY IN OH MI GA SC FL MO WI MN ND SD NE NJ PA MD IL IA CA VA NC DC WV AR AL MS AL MI WA OR ID LA FL KS TN MA KY OK TX TX CT AZ NV NM MT WY CO UT DC WY Country: KOREA CHINA CANADA AUSTRALIA JAPAN EMEA SWEDEN ITALY
Lot / Code Information
Lot Number 559070 527660 677630 191210 219890 677620 758460 089950 283100 358850 283080 374620 321750 321770 358830 374580 374590 420310 420320 434060 358860 381760 321690 358840 468200 381770 381780 381780R 321710 434070 420290 468210 023420 011510 864760 093450 093460 885140 855480 975650 828760 061480 331670 103080 131270 159350 116110 223220 116110R 587400 181490 418770 634280 664240 783170 716000 906810 685020 882160 882170 881950 715990 986210 396500 986200 906820 029310 126100 163080 247440 293200 293210 163090 126090 920640 920640R 481960 073030 374570 442040 442050 318630 479060 509960 509930 450480 183670 479050 576240 543440 543450 625770 593670 639750 670660 758590 741610 481970 943600 808440 917680 951040 780300 833290 851020 873620 481950 018270 999420 076780
Other Recalls from Zimmer Biomet, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0696-2021 | Class II | Spinal Rod Cutter, Item number 00392500200. The... | Nov 20, 2020 |
| Z-0570-2021 | Class II | Polaris 5.5 Spinal System and Polaris 5.5/Cyphe... | Nov 17, 2020 |
| Z-0372-2021 | Class II | ZCA All Poly Acetabular Cup Longevity Crosslink... | Sep 24, 2020 |
| Z-0345-2021 | Class II | ZCA All Poly Acetabular Cup Longevity Crosslink... | Sep 24, 2020 |
| Z-0347-2021 | Class II | ZCA All Poly Acetabular Cup Longevity Crosslink... | Sep 24, 2020 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.